Press release
Key Influencer in the Therapeutic Nuclear Drug Market 2025: Increasing Prevalence Of Cancer Is Driving The Growth Of The Therapeutic Nuclear Drug Market Driver
Therapeutic Nuclear Drug Market Growth
The surge in incidences of cancer is anticipated to fuel the expansion of the therapeutic nuclear drug market in the future. Cancer, identified by the uninhibited proliferation and dissemination of abnormal cells, is becoming increasingly common due to bettered detection techniques, lifestyle habits, environmental exposure, and genetic predispositions. Therapeutic nuclear medications serve as a crucial tool in the fight against cancer- they provide patients with precise and effective treatment thereby decreasing the size of tumors, reducing discomforts, and enhancing their quality of life. For instance, the World Health Organization, a United Nations agency based in Switzerland, predicted in February 2024 that there will be over 35 million new cancer cases by 2050. This marks a 77% increase from the projected 20 million cases in 2022. Hence, the rising incidences of cancer is propelling the growth of the therapeutic nuclear drug market.
Get Your Therapeutic Nuclear Drug Market Report Here:
https://www.thebusinessresearchcompany.com/report/therapeutic-nuclear-drug-global-market-report
What is the projected compound annual growth rate (CAGR) of the therapeutic nuclear drug market from 2025 to 2034, and what factors influence it?
The market size for nuclear therapeutic drugs has witnessed rapid expansion in the recent past. In 2024, the market was valued at $1.94 billion and it is projected to reach $2.23 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.1%. The significant growth during the historic period can be linked to factors such as more regulatory approvals, enhanced use of individualized patient data, advancements in dosimetry techniques, heightened awareness regarding nuclear medication, and a surge in investment in research and development endeavors.
The market size of therapeutic nuclear drugs is projected to witness rapid expansion in the coming years, reaching $3.86 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 14.7%. The anticipated growth during the forecast period is due to the shift towards personalized medicine, increasing needs for improvements in healthcare infrastructure, the expanding older population, a higher number of diagnostic imaging procedures and personalized care delivery's emergence. The forecast period is predicted to experience significant trends such as nanoparticle-based delivery systems, advancements in radionuclide therapy, hybrid imaging systems, growth in radiopharmaceutical manufacturing, development of alpha-emitting radiopharmaceuticals, and the integration of machine learning and artificial intelligence.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19729&type=smp
How are the latest trends influencing the growth of the therapeutic nuclear drug market?
Major firms in the therapeutic nuclear drug sector are establishing strategic alliances to secure a leading position in the market. These collaborations are crucial in boosting research and development abilities, speeding up the introduction of new therapies, and widening the availability of ground-breaking treatments through the combined utilization of resources and expertise. For example, in July 2022, DeepC, a software company headquartered in Germany, entered into a partnership with PAIRE, a US-based firm specializing in AI solutions, with the objective of improving nuclear medicine diagnostics. This collaboration aims to bolster the accuracy and efficiency of nuclear medicine diagnostics by incorporating PAIRE's AI solution, Pionus, into DeepC's deepcOS platform to enhance PET/CT scan analysis.
What are the major segments of the therapeutic nuclear drug market and their role in driving growth?
The therapeutic nuclear drugmarket covered in this report is segmented -
1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types
2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes
3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications
Subsegments:
1) Radium-223: Indications for prostate cancer, Mechanism of action, Dosage forms
2) Lutetium-177: Applications in neuroendocrine tumors, Treatment protocols, Combination therapies
3) Iodine-131: Use in thyroid cancer, Dosage and administration, Safety and efficacy
4) Other Types: Additional therapeutic isotopes, Emerging treatments, Research and development trends
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19729
Which geographical regions are pioneering growth in the therapeutic nuclear drug market?
North America was the largest region in the therapeutic nuclear drug market in 2024. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the therapeutic nuclear drug market?
Major companies operating in the therapeutic nuclear drug market are Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19729&type=smp
What Is Covered In The Therapeutic Nuclear Drug Global Market Report?
•Market Size Forecast: Examine the therapeutic nuclear drug market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the therapeutic nuclear drug market for a structured understanding.
•Key Players Overview: Analyze major players in the therapeutic nuclear drug market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the therapeutic nuclear drug market.
•Segment Contributions: Evaluate how different segments drive overall growth in the therapeutic nuclear drug market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the therapeutic nuclear drug market.
•Industry Challenges: Identify potential risks and obstacles affecting the therapeutic nuclear drug market.
•Competitive Landscape: Review strategic developments in the therapeutic nuclear drug market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Therapeutic Nuclear Drug Market 2025: Increasing Prevalence Of Cancer Is Driving The Growth Of The Therapeutic Nuclear Drug Market Driver here
News-ID: 3943346 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
